Top section
Top section
New $75m partnership to develop treatment for lymphoma was “catalyst for investors”
Tech-focused investment company uses new mechanism to suspend trading as it offers shares as part of a $100m capital raising and investment programme
Books multiple times covered at £9.15 a share as commodities trader exits longstanding investment
More articles
More articles
More articles
-
Europe’s most prominent IPO, the Frankfurt listing of Volkswagen’s truck unit Traton, has been on the road for a week and sources have expressed confidence in the deal’s viability. -
Huatai Securities, the Chinese brokerage, has set the price range for its $1.65bn sale of global depositary receipts on the London Stock Exchange, enticing investors with a healthy discount to the Shanghai-listed A shares.
-
Hutchison China MediTech (Chi-Med) is looking to launch bookbuilding for its Hong Kong listing as early as June 21 for proceeds of around $600m, according to a source close to the deal.
-
HSBC has chosen its new convertible bonds boss in EMEA from its own ranks, according to a source familiar with the matter.
-
Chinese healthcare company Jinxin Fertility Group has kicked off a week-long roadshow for its Hong Kong IPO, looking to raise up to HK$2.99bn ($381.4m) from the deal, said a source close to the situation.
-
IPO investors appear to be putting a high premium on company fundamentals when looking at new listings, focusing less on thematic trends and more on underlying numbers, as shown by the listings of Watches of Switzerland and Marel.
Sub-sections
shared comment list
